Gout

Latest News

FDA Approves Duzallo for Hyperuricemia Associated With Uncontrolled Gout

FDA Approves Duzallo for Hyperuricemia Associated With Uncontrolled Gout

The US FDA has approved a new fixed-dose and dual-mechanism treatment option for uncontrolled gout.

High Levels of Serum Uric Acid May Increase Risk for Dementia in the Elderly

High Levels of Serum Uric Acid May Increase Risk for Dementia in the Elderly

Older adults with high serum uric acid levels might be at increased risk of developing vascular or mixed dementia.

Lesinurad, Febuxostat Combination Treatment Improves Tophaceous Gout Symptoms

Lesinurad, Febuxostat Combination Treatment Improves Tophaceous Gout Symptoms

Patients with tophaceous gout undergoing combination therapy with lesinurad and febuxostat showed a greater degree of symptom resolution than with febuxostat monotherapy.

Recall: Gout Pills Found in Platelet Inhibitor Sample Bottle

Recall: Gout Pills Found in Platelet Inhibitor Sample Bottle

Accidental patient dosing with Zurampic can potentially cause adverse renal effects such as acute renal failure; this is more common if Zurampic is given alone without a xanthine oxidase inhibitor.

Analysis of Factors Improving Rx Adherence in Patients with Gout

Analysis of Factors Improving Rx Adherence in Patients with Gout

Belief about medicines, presence of comorbidity, and being married positively influence adherence to medication.

DASH Diet May Help Lower Occurrence of Gout

DASH Diet May Help Lower Occurrence of Gout

Following the diet may be a good option for patients who prefer to avoid medication.

Low Serum Uric Acid Levels Significantly Reduce Gout Risk

Low Serum Uric Acid Levels Significantly Reduce Gout Risk

Reduced levels of serum uric acid are associated with markedly fewer new-onset gout and gout flares.

Age, Tophi Linked to Mortality in Gout

Age, Tophi Linked to Mortality in Gout

The presence of tophi at baseline was associated with an almost 3-fold increased risk for death from all causes.

Systematic Review Analyzes Antihypertensive Effects of Hyperuricemia Pharmacotherapy

Systematic Review Analyzes Antihypertensive Effects of Hyperuricemia Pharmacotherapy

There was low quality evidence from three trials indicating no reduction in systolic (-6.2mmHg, 95% CI: -12.8 to 0.5) or diastolic (-3.9mmHg, 95% CI: -9.2 to 1.4) 24-hour ambulatory BP with uric acid lowering drugs vs. placebo.

Allopurinol Use In Concomitant Gout and Diabetes Lowers Cardiovascular Event Risk

Allopurinol Use In Concomitant Gout and Diabetes Lowers Cardiovascular Event Risk

Study analyzes insurance claims data to examine the relationship between allopurinol use in patients with both gout and diabetes and its effect on cardiovascular event risk.

Sign Up for Free e-newsletters